SEC 13F Intelligence

KARUNA THERAPEUTICS INC

CUSIP 48576A100

Karuna Therapeutics Inc has 230 institutional holders in Filings Flow’s 13F database, together reporting 21.73M shares worth $3.1B as of Q4 2022. The largest reported holders are Sofinnova Investments, Inc., Hbk Investments L P, and Norges Bank.

Institutional Holders
230
Q4 2022
Reported Value
$3.1B
Ticker
unmapped
private placement or foreign
Quarters Tracked
5

Ownership Trend

Institutional holders
Q2 ’19: 31Q2 ’19Q3 ’19: 37Q3 ’19Q2 ’21: 142Q2 ’21Q4 ’21: 153Q4 ’21Q4 ’22: 230Q4 ’22filingsflow.com
Total reported value
Q2 ’19: $117MQ2 ’19Q3 ’19: $108MQ3 ’19Q2 ’21: $27.9BQ2 ’21Q4 ’21: $34.3BQ4 ’21Q4 ’22: $3.1BQ4 ’22filingsflow.com

Holders

Mixed quarters
Manager% of PortfolioValueSharesQuarter
Sofinnova Investments, Inc.$2.6B AUM24.45%$437M1.38MQ2 2024OLDER
HBK INVESTMENTS L P$9.9B AUM12.98%$201M636.0KQ4 2024OLDER
Erste Asset Management GmbH$10.8B AUM0.03%$2M7.1KQ3 2024OLDER
Legal & General Group Plc$432.4B AUM0.00%$10M32.8KQ1 2025

Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.